Cargando…

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma

Background: Patient-derived organoids (PDOs) and xenografts (PDXs) have been extensively studied for drug-screening. However, their usage is limited due to lengthy establishment time, high engraftment failure rates and different tumor microenvironment from original tumors. To overcome the limitation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dae Won, Beato, Francisca, Kim, Youngchul, Tassielli, Alexandra F., Dai, Ruifan, Denbo, Jason W., Hodul, Pamela J., Malafa, Mokenge P., Fleming, Jason B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503742/ https://www.ncbi.nlm.nih.gov/pubmed/37713330 http://dx.doi.org/10.18632/oncotarget.28508

Ejemplares similares

Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, J.M., et al.
Publicado: (2022)

The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization
por: Powers, Benjamin D., et al.
Publicado: (2023)

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, JM, et al.
Publicado: (2023)

Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study
por: Powers, Benjamin D., et al.
Publicado: (2022)

Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
por: Pointer, David T., et al.
Publicado: (2020)

Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay
por: Rios Perez, Mayrim V, et al.
Publicado: (2015)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
por: Hall, MacLean, et al.
Publicado: (2016)

Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer
por: Bibok, Andras, et al.
Publicado: (2021)

Multimodality Management of “Borderline Resectable” Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience
por: Ambe, Chenwi M., et al.
Publicado: (2017)

Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017)

Pilot trial of remote monitoring to prevent malnutrition after hepatopancreatobiliary surgery
por: Allenson, Kelvin, et al.
Publicado: (2021)

TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma
por: Glazer, Evan S., et al.
Publicado: (2016)

Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis
por: Nelson, Nadine, et al.
Publicado: (2015)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Vitamin E δ-Tocotrienol Induces p27(Kip1)-Dependent Cell-Cycle Arrest in Pancreatic Cancer Cells via an E2F-1-Dependent Mechanism
por: Hodul, Pamela J., et al.
Publicado: (2013)

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
por: van den Tempel, Nathalie, et al.
Publicado: (2018)

Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
por: Rothermel, Luke D., et al.
Publicado: (2020)

A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms
por: Park, Margaret A, et al.
Publicado: (2022)

Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature
por: Ambe, Chenwi M., et al.
Publicado: (2016)

Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()
por: Challa, Sridevi, et al.
Publicado: (2020)

δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2017)

Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma
por: Almhanna, Khaldoun, et al.
Publicado: (2016)

Minimally invasive appendectomy for resection of appendiceal mucocele: Case series and review of the literature
por: Orcutt, Sonia T., et al.
Publicado: (2017)

Implementing Telemedicine into the Initial Assessment of Patients with Complex Gastrointestinal Cancer: Lessons from the COVID-19 Pandemic
por: Manguso, Nicholas R., et al.
Publicado: (2021)

Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2021)

H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinoma
por: Ávila-López, P. A., et al.
Publicado: (2021)

ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer
por: Isacoff, William H., et al.
Publicado: (2022)

Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes
por: Gardiner, Anna, et al.
Publicado: (2022)

Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
por: Xing, Hai-Bo, et al.
Publicado: (2018)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer
por: Permuth, Jennifer B., et al.
Publicado: (2021)

Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
por: Michalski, C W, et al.
Publicado: (2008)

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”
por: Xing, Hai-Bo, et al.
Publicado: (2022)

Chick Embryo Assay as Chemosensitivity Test for Malignant Glioma
por: Shoin, Katsuo, et al.
Publicado: (1991)

Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
por: Gündel, Beate, et al.
Publicado: (2021)

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2019)

Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
por: Abuodeh, Yazan, et al.
Publicado: (2016)

DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
por: Zhang, Geng, et al.
Publicado: (2012)

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia
por: Springett, Gregory M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7g8lce4dt6i5fhuamh45eapjmu